+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Regional Outlook and Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 275 Pages
  • April 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5972543
The Global Cyclodextrin Market size is expected to reach $504.3 million by 2031, rising at a market growth of 5.6% CAGR during the forecast period. In the year 2023, the market attained a volume of 873.18 Tonnes, experiencing a growth of 17.7% (2020-2023).

Cyclodextrins are well-known for improving the solubility and bioavailability of poorly soluble drugs. Therefore, the pharmaceutical segment would acquire 34.8% revenue share by 2031. Moreover, the pharmaceutical segment utilized 289.62 Tonnes of Cyclodextrin in 2023. Many active pharmaceutical ingredients (APIs) have limited solubility in aqueous solutions, hindering their absorption and efficacy in pharmaceutical formulations.



Many drugs used to treat infectious diseases face challenges related to poor solubility, which can hinder their effectiveness. Cyclodextrins, with their ability to form inclusion complexes, can improve the solubility of these drugs. In addition, these increase their aqueous solubility by encapsulating poorly soluble drugs within their hydrophobic cavity, making them more bioavailable and efficacious. Thus, increasing drug formulation for infectious diseases drives the market’s growth.

Additionally, as urbanization progresses and incomes rise, there’s a notable shift in dietary preferences towards convenience and processed foods. These find extensive applications in the food and beverage industry as encapsulants for flavors, fragrances, and other functional ingredients. Therefore, the growing middle-class population and urbanization propel the market’s growth.

However, these can uniquely form inclusion complexes with poorly soluble drugs, improving their solubility and bioavailability. This property is particularly valuable in drug delivery systems were increasing the solubility and bioavailability of active pharmaceutical ingredients (APIs) can enhance drug efficacy and therapeutic outcomes. Thus, drug delivery system innovations are propelling the market’s growth.

End-use Outlook

On the basis of end-use, the market is segmented into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. The chemical segment held 15.4% growth rate in the market in 2023. These have a wide range of applications in the chemical industry. They are utilized as complex agents, solubilizers, stabilizers, and carriers for various chemical compounds. Moreover, in terms of volume, the chemical segment utilized 138.44 Tonnes of Cyclodextrin in 2023.



Type Outlook

Based on type, the market is divided into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. The alpha-cyclodextrin segment attained 24.3% revenue share in the market in 2023. Alpha-cyclodextrin offers unique properties that make it particularly suitable for certain applications. Moreover, in terms of volume, the alpha-variant segment utilized 72.57 tonnes of Cyclodextrin in 2023.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 27.1% revenue share in the market. Consumers in the Asia Pacific region is becoming increasingly aware of health and wellness trends, leading to a surge in demand for functional foods, dietary supplements, and personal care products with added health benefits. In terms of volume, the Asia Pacific region would utilize 1,22,154.38 tonnes of Cyclodextrin by 2031.

List of Key Companies Profiled

  • Midas Pharma Gmbh
  • Wacker Chemie AG
  • Roquette Freres SA
  • Cambrex Corporation
  • Wellona Pharma
  • Cayman Chemical Company, Inc.
  • Cyclolab Kft.
  • Ligand Pharmaceuticals Incorporated
  • Tocopharm Co. Limited
  • Merck KGaA

Market Report Segmentation

By Type (Volume, Tonnes, USD Million, 2020-2031)
  • Beta-Cyclodextrin
  • Alpha-Cyclodextrin
  • Gamma-Cyclodextrin
By End-use (Volume, Tonnes, USD Million, 2020-2031)
  • Pharmaceutical
  • Food
  • Cosmetics & Personal Care
  • Chemical
  • Textile
  • Others
By Geography (Volume, Tonnes, USD Million, 2020-2031)
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cyclodextrin Market, by Type
1.4.2 Global Cyclodextrin Market, by End-use
1.4.3 Global Cyclodextrin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Cyclodextrin Market by Type
4.1 Global Beta-Cyclodextrin Market by Region
4.2 Global Alpha-Cyclodextrin Market by Region
4.3 Global Gamma-Cyclodextrin Market by Region
Chapter 5. Global Cyclodextrin Market by End-use
5.1 Global Pharmaceutical Market by Region
5.2 Global Food Market by Region
5.3 Global Cosmetics & Personal Care Market by Region
5.4 Global Chemical Market by Region
5.5 Global Textile Market by Region
5.6 Global Others Market by Region
Chapter 6. Global Cyclodextrin Market by Region
6.1 North America Cyclodextrin Market
6.1.1 North America Cyclodextrin Market by Type
6.1.1.1 North America Beta-Cyclodextrin Market by Country
6.1.1.2 North America Alpha-Cyclodextrin Market by Country
6.1.1.3 North America Gamma-Cyclodextrin Market by Country
6.1.2 North America Cyclodextrin Market by End-use
6.1.2.1 North America Pharmaceutical Market by Country
6.1.2.2 North America Food Market by Country
6.1.2.3 North America Cosmetics & Personal Care Market by Country
6.1.2.4 North America Chemical Market by Country
6.1.2.5 North America Textile Market by Country
6.1.2.6 North America Others Market by Country
6.1.3 North America Cyclodextrin Market by Country
6.1.3.1 US Cyclodextrin Market
6.1.3.1.1 US Cyclodextrin Market by Type
6.1.3.1.2 US Cyclodextrin Market by End-use
6.1.3.2 Canada Cyclodextrin Market
6.1.3.2.1 Canada Cyclodextrin Market by Type
6.1.3.2.2 Canada Cyclodextrin Market by End-use
6.1.3.3 Mexico Cyclodextrin Market
6.1.3.3.1 Mexico Cyclodextrin Market by Type
6.1.3.3.2 Mexico Cyclodextrin Market by End-use
6.1.3.4 Rest of North America Cyclodextrin Market
6.1.3.4.1 Rest of North America Cyclodextrin Market by Type
6.1.3.4.2 Rest of North America Cyclodextrin Market by End-use
6.2 Europe Cyclodextrin Market
6.2.1 Europe Cyclodextrin Market by Type
6.2.1.1 Europe Beta-Cyclodextrin Market by Country
6.2.1.2 Europe Alpha-Cyclodextrin Market by Country
6.2.1.3 Europe Gamma-Cyclodextrin Market by Country
6.2.2 Europe Cyclodextrin Market by End-use
6.2.2.1 Europe Pharmaceutical Market by Country
6.2.2.2 Europe Food Market by Country
6.2.2.3 Europe Cosmetics & Personal Care Market by Country
6.2.2.4 Europe Chemical Market by Country
6.2.2.5 Europe Textile Market by Country
6.2.2.6 Europe Others Market by Country
6.2.3 Europe Cyclodextrin Market by Country
6.2.3.1 Germany Cyclodextrin Market
6.2.3.1.1 Germany Cyclodextrin Market by Type
6.2.3.1.2 Germany Cyclodextrin Market by End-use
6.2.3.2 UK Cyclodextrin Market
6.2.3.2.1 UK Cyclodextrin Market by Type
6.2.3.2.2 UK Cyclodextrin Market by End-use
6.2.3.3 France Cyclodextrin Market
6.2.3.3.1 France Cyclodextrin Market by Type
6.2.3.3.2 France Cyclodextrin Market by End-use
6.2.3.4 Russia Cyclodextrin Market
6.2.3.4.1 Russia Cyclodextrin Market by Type
6.2.3.4.2 Russia Cyclodextrin Market by End-use
6.2.3.5 Spain Cyclodextrin Market
6.2.3.5.1 Spain Cyclodextrin Market by Type
6.2.3.5.2 Spain Cyclodextrin Market by End-use
6.2.3.6 Italy Cyclodextrin Market
6.2.3.6.1 Italy Cyclodextrin Market by Type
6.2.3.6.2 Italy Cyclodextrin Market by End-use
6.2.3.7 Rest of Europe Cyclodextrin Market
6.2.3.7.1 Rest of Europe Cyclodextrin Market by Type
6.2.3.7.2 Rest of Europe Cyclodextrin Market by End-use
6.3 Asia Pacific Cyclodextrin Market
6.3.1 Asia Pacific Cyclodextrin Market by Type
6.3.1.1 Asia Pacific Beta-Cyclodextrin Market by Country
6.3.1.2 Asia Pacific Alpha-Cyclodextrin Market by Country
6.3.1.3 Asia Pacific Gamma-Cyclodextrin Market by Country
6.3.2 Asia Pacific Cyclodextrin Market by End-use
6.3.2.1 Asia Pacific Pharmaceutical Market by Country
6.3.2.2 Asia Pacific Food Market by Country
6.3.2.3 Asia Pacific Cosmetics & Personal Care Market by Country
6.3.2.4 Asia Pacific Chemical Market by Country
6.3.2.5 Asia Pacific Textile Market by Country
6.3.2.6 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Cyclodextrin Market by Country
6.3.3.1 China Cyclodextrin Market
6.3.3.1.1 China Cyclodextrin Market by Type
6.3.3.1.2 China Cyclodextrin Market by End-use
6.3.3.2 Japan Cyclodextrin Market
6.3.3.2.1 Japan Cyclodextrin Market by Type
6.3.3.2.2 Japan Cyclodextrin Market by End-use
6.3.3.3 India Cyclodextrin Market
6.3.3.3.1 India Cyclodextrin Market by Type
6.3.3.3.2 India Cyclodextrin Market by End-use
6.3.3.4 South Korea Cyclodextrin Market
6.3.3.4.1 South Korea Cyclodextrin Market by Type
6.3.3.4.2 South Korea Cyclodextrin Market by End-use
6.3.3.5 Singapore Cyclodextrin Market
6.3.3.5.1 Singapore Cyclodextrin Market by Type
6.3.3.5.2 Singapore Cyclodextrin Market by End-use
6.3.3.6 Malaysia Cyclodextrin Market
6.3.3.6.1 Malaysia Cyclodextrin Market by Type
6.3.3.6.2 Malaysia Cyclodextrin Market by End-use
6.3.3.7 Rest of Asia Pacific Cyclodextrin Market
6.3.3.7.1 Rest of Asia Pacific Cyclodextrin Market by Type
6.3.3.7.2 Rest of Asia Pacific Cyclodextrin Market by End-use
6.4 LAMEA Cyclodextrin Market
6.4.1 LAMEA Cyclodextrin Market by Type
6.4.1.1 LAMEA Beta-Cyclodextrin Market by Country
6.4.1.2 LAMEA Alpha-Cyclodextrin Market by Country
6.4.1.3 LAMEA Gamma-Cyclodextrin Market by Country
6.4.2 LAMEA Cyclodextrin Market by End-use
6.4.2.1 LAMEA Pharmaceutical Market by Country
6.4.2.2 LAMEA Food Market by Country
6.4.2.3 LAMEA Cosmetics & Personal Care Market by Country
6.4.2.4 LAMEA Chemical Market by Country
6.4.2.5 LAMEA Textile Market by Country
6.4.2.6 LAMEA Others Market by Country
6.4.3 LAMEA Cyclodextrin Market by Country
6.4.3.1 Brazil Cyclodextrin Market
6.4.3.1.1 Brazil Cyclodextrin Market by Type
6.4.3.1.2 Brazil Cyclodextrin Market by End-use
6.4.3.2 Argentina Cyclodextrin Market
6.4.3.2.1 Argentina Cyclodextrin Market by Type
6.4.3.2.2 Argentina Cyclodextrin Market by End-use
6.4.3.3 UAE Cyclodextrin Market
6.4.3.3.1 UAE Cyclodextrin Market by Type
6.4.3.3.2 UAE Cyclodextrin Market by End-use
6.4.3.4 Saudi Arabia Cyclodextrin Market
6.4.3.4.1 Saudi Arabia Cyclodextrin Market by Type
6.4.3.4.2 Saudi Arabia Cyclodextrin Market by End-use
6.4.3.5 South Africa Cyclodextrin Market
6.4.3.5.1 South Africa Cyclodextrin Market by Type
6.4.3.5.2 South Africa Cyclodextrin Market by End-use
6.4.3.6 Nigeria Cyclodextrin Market
6.4.3.6.1 Nigeria Cyclodextrin Market by Type
6.4.3.6.2 Nigeria Cyclodextrin Market by End-use
6.4.3.7 Rest of LAMEA Cyclodextrin Market
6.4.3.7.1 Rest of LAMEA Cyclodextrin Market by Type
6.4.3.7.2 Rest of LAMEA Cyclodextrin Market by End-use
Chapter 7. Company Profiles
7.1 Midas Pharma GmbH
7.1.1 Company Overview
7.2 Wacker Chemie AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 Roquette Freres SA
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Cambrex Corporation
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Wellona Pharma
7.5.1 Company Overview
7.6 Cayman Chemical Company, Inc.
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Cyclolab Kft.
7.7.1 Company Overview
7.8 Ligand Pharmaceuticals Incorporated
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expenses
7.9 Tocopharm Co. Limited
7.9.1 Company Overview
7.10. Merck KGaA
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Chapter 8. Winning Imperatives of Cyclodextrin Market

Companies Mentioned

  • Midas Pharma Gmbh
  • Wacker Chemie AG
  • Roquette Freres SA
  • Cambrex Corporation
  • Wellona Pharma
  • Cayman Chemical Company, Inc.
  • Cyclolab Kft.
  • Ligand Pharmaceuticals Incorporated
  • Tocopharm Co. Limited
  • Merck KGaA

Methodology

Loading
LOADING...